HCA Healthcare, Inc. (NYSE:HCA) Declares $0.78 Quarterly Dividend

HCA Healthcare, Inc. (NYSE:HCA) declared a quarterly dividend on Thursday, July 23rd. Stockholders of record on Wednesday, September 16th will be paid a dividend of 0.78 per share on Wednesday, September 30th. This represents a c) annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th.

HCA Healthcare has increased its dividend by an average of 0.3%annually over the last three years and has increased its dividend every year for the last 6 years. HCA Healthcare has a payout ratio of 11.1% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect HCA Healthcare to earn $32.05 per share next year, which means the company should continue to be able to cover its $3.12 annual dividend with an expected future payout ratio of 9.7%.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $427.51 on Monday. The business’s 50 day moving average price is $404.99 and its 200 day moving average price is $432.69. The company has a market cap of $92.56 billion, a price-to-earnings ratio of 14.31, a PEG ratio of 1.40 and a beta of 1.10. HCA Healthcare has a one year low of $353.99 and a one year high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same period last year, the company earned $6.84 EPS. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, analysts predict that HCA Healthcare will post 29.42 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HCA. KeyCorp cut their price target on shares of HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating for the company in a report on Monday, July 27th. Cantor Fitzgerald cut their target price on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. Truist Financial lowered their target price on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a research note on Monday, July 27th. Royal Bank Of Canada restated an “outperform” rating and issued a $435.00 price objective on shares of HCA Healthcare in a report on Tuesday, September 8th. Finally, The Goldman Sachs Group dropped their price objective on HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research note on Tuesday, July 28th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $462.64.

HCA Healthcare Company Profile

HCA Healthcare, Inc (NYSE:HCA) is a healthcare services company that operates hospitals and other healthcare facilities. Its network provides a broad range of medical services, including emergency care, inpatient and outpatient treatment, surgery, diagnostic services, and maternity care.

The company also operates ambulatory surgery centers, urgent care facilities, physician practices, and other outpatient locations. HCA Healthcare serves patients through facilities located across the United States, as well as through HCA Healthcare UK, its healthcare operations in the United Kingdom.

HCA Healthcare was founded in 1968 by Dr.